Publication | Open Access

Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes

ThrombosisBetter Clinical OutcomesCovid-19 PandemicInflammatory MarkerMetformin UseCovid-19MedicineEpidemiologyOxidative Stress